| (Values in U.S. Thousands) | Dec, 2022 | Dec, 2021 | Dec, 2020 | Feb, 2026 | Feb, 2026 |
| Sales | 0 | 1,130 | 860 | 0 | 0 |
| Sales Growth | -100.00% | +31.40% | unch | unch | unch |
| Net Income | -83,890 | -48,960 | -23,740 | 0 | 0 |
| Net Income Growth | -71.34% | -106.23% | unch | unch | unch |
Dice Therapeutics Inc
(DICE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
DICE Therapeutics Inc. is a biopharmaceutical company. Its proprietary technology platform to build a pipeline of novel oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. DICE Therapeutics Inc. is based in SOUTH SAN FRANCISCO, Calif.
Fiscal Year End Date: 12/31